Researchers at McGill University and other institutes recently carried out a study aimed at identifying biomarkers and psychosocial factors associated with the development of chronic pain conditions. Their findings, published in Nature Human Behavior, were obtained by analyzing data from a large biomedical database, namely the UK Biobank, using advanced machine learning techniques.

A new device that monitors the waste-removal system of the brain may help to prevent Alzheimer’s and other neurological diseases, according to a study published today in Nature Biomedical Engineering.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a machine learning tool that can help doctors manage blood sugar levels in patients recovering from heart surgery, a critical but often difficult task in the intensive care unit (ICU). The findings appear in npj Digital Medicine.

Associate Professor Dr. Hadi Mohammadi runs the Heart Valve Performance Laboratory at UBCO’s School of Engineering. He, along with Dr. Dylan Goode, has been testing an MHV created in their lab that may—after clinical trials—supersede mechanical valves currently available for people living with heart disease.

Medtronic (NYSE: MDT)+
announced today that the FDA accepted its new Nellcor technology into its STeP program.

The company said in a news release that the latest clearance marks a significant step forward in gastrointestinal (GI) motility monitoring. It offers clinicians an advanced, non-invasive tool for assessing whole-gut transit times with unmatched accuracy and patient comfort.

European regulatory approval paves the way for Dermalyser’s clinical rollout, enhancing early skin cancer diagnosis through advanced AI technology.

Researchers at the University of Southern California and other institutes recently developed a new flexible, wireless and battery-free implantable stimulator that could overcome some of the limitations of previously introduced pain-management solutions.